Undergraduate Education: BS, Biochemistry, 2004
Medical School: MD, Washington University School of Medicine, 2009
Post Graduate Education: MS, Washington University School of Medicine, 2009
Internship: Internal Medicine, St. John’s Mercy Medical Center, 2010
Residency: Ophthalmology,Washington University School of Medicine, 2013
Fellowships: Medical Retina, Moorfields Eye Hospital, 2014
Surgical Retina, University of British Columbia, 2015
Board Certification: American Board of Ophthalmology
Memberships: American Academy of Ophthalmology (AAO)
Washington Academy of Eye Physicians and Surgeons (WAEPS)
Association for Research in Vision and Ophthalmology (ARVO)
Dr. Lee specializes in vitreoretinal and macular diseases including epiretinal membranes, macular hole repair, retinal detachment repair, and hereditary macular dystrophies
Dr. Lee is interested in the intersection of large clinical medical datasets and using non-traditional computational techniques to both analyze and visualize the results. He has created programs to process next-generation sequencing data in supercomputing environments and analyzed numerous Big Data sources including CMS, US Census, and NLM MEDLINE archives.Visit his research website here.
2014 Honorary Research Fellow - University College London, London UK
2014 Honorary Research Fellow - City University, London UK
2014 Honorary Research Fellow - Moorfields Eye Hospital, London UK
2009 The Doctor William Ellis Research Prize in Ophthalmology
2008 Doris P. and Harry I. Wexler Research Prize in Ophthalmology
2000-2004 Harvard University, Cambridge MA, High Honors, magna cum laude
Butt T, Lee A, Lee C, Tufail A; UK AMD EMR Study Group. The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomes. BMJ Open. 2015 May 5;5(5):e006535.
Lee AY, Lee CS, Butt T, Xing W, Johnston RL, Chakravarthy U, Egan C, Akerele T, McKibbin M, Downey L, Natha S, Bailey C, Khan R, Antcliff R, Varma A, Kumar V, Tsaloumas M, Mandal K, Liew G, Keane PA, Sim D, Bunce C, Tufail A; on behalf of UK AMD EMR Users Group. UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12. Br J Ophthalmol. 2015 Feb 13.
Lee AY, Akileswaran L, Tibbetts MD, Garg SJ, Van Gelder RN. Identification of Torque Teno Virus in Culture-Negative Endophthalmitis by Representational Deep DNA Sequencing. Ophthalmology. 2014 Nov 24. pii: S0161-6420(14)00820- 3.
Muthappan V, Lee AY, Lamprecht TL, Akileswaran L, Dintzis SM, Lee C, Magrini V, Mardis ER, Shendure J, Van Gelder RN. Biome representational in silico karyotyping. Genome Res. 2011 Apr; 21 (4):626-33.
Lee AY, Raya AK, Kymes S, Shiels A, Brantley MA. The Pharmacogenetics of Complement Factor H (Y402H) and the Treatment of Exudative Age-Related Macular Degeneration with Ranibizumab. Br J Ophthalmol. 2008 Dec 17.